Publication | Closed Access

A Phase I Trial of Daily Oral 4′-N-Benzoyl-Staurosporine in Combination with Protracted Continuous Infusion 5-Fluorouracil in Patients with Advanced Solid Malignancies

OncologyProtracted Continuous InfusionMedicineAdvanced Solid MalignanciesPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyDaily Oral 4′-N-benzoyl-staurosporineCancer Research